Tapan Kadia Selected Research

Tapan Kadia Research Topics

Disease

64	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 08/2010
23	Neoplasms (Cancer) 10/2022 - 08/2011
23	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2021 - 01/2012
18	Leukemia 10/2022 - 08/2010
17	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022 - 06/2014
17	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 01/2010
16	Philadelphia Chromosome 09/2022 - 02/2009
8	Primary Myelofibrosis (Myelosclerosis) 11/2021 - 08/2012
8	Residual Neoplasm 01/2021 - 02/2016
6	Acute Promyelocytic Leukemia 01/2022 - 06/2011
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 06/2012
5	Anemia 01/2022 - 08/2009
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 06/2011
4	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2018
4	Exanthema (Rash) 01/2021 - 11/2015
4	Blast Crisis (Blast Phase) 01/2021 - 08/2012
4	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 02/2012
4	Pathologic Complete Response 09/2019 - 05/2015
3	Lymphoma (Lymphomas) 01/2022 - 06/2012
3	Infections 01/2022 - 11/2015
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 07/2012
2	Leukocytosis (Pleocytosis) 01/2022 - 01/2017
2	Hypertension (High Blood Pressure) 12/2020 - 11/2015
2	Fatigue 09/2019 - 11/2018
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2018 - 04/2016
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2017 - 04/2014
2	Diarrhea 01/2016 - 06/2014
2	Nausea 01/2016 - 01/2015
2	Refractory Anemia with Excess of Blasts (RAEM) 10/2014 - 10/2013
2	Myeloid Leukemia (Leukemia, Myelocytic) 02/2013 - 07/2012
1	Invasive Fungal Infections 10/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Hyperuricemia 01/2022
1	Hyperbilirubinemia 01/2022

Drug/Important Bio-Agent (IBA)

15	Tyrosine Kinase InhibitorsIBA 09/2022 - 08/2011
14	venetoclaxIBA 10/2022 - 10/2016
14	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 08/2010
12	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 06/2013
10	Decitabine FDA Link 01/2022 - 09/2012
7	Inotuzumab OzogamicinIBA 01/2022 - 03/2015
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2012
6	Core Binding Factors (Core-Binding Factor)IBA 01/2022 - 08/2010
6	ruxolitinibIBA 11/2021 - 08/2012
6	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2010
5	Sorafenib (BAY 43-9006)FDA Link 11/2020 - 06/2013
5	Dasatinib (BMS 354825)FDA Link 11/2020 - 08/2011
5	Arsenic Trioxide (Trisenox)FDA Link 09/2019 - 05/2015
5	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 09/2019 - 11/2013
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2019 - 05/2015
5	Clofarabine (Clolar)FDA Link 02/2017 - 09/2012
4	blinatumomabIBA 09/2022 - 10/2018
4	ibrutinibIBA 12/2021 - 01/2019
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 06/2014
4	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021 - 12/2012
4	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 05/2015
4	nilotinib FDA Link 11/2016 - 01/2010
3	Lenalidomide (CC 5013)FDA Link 10/2022 - 01/2015
3	fludarabineIBA 12/2021 - 08/2010
3	Rituximab (Mabthera)FDA Link 12/2021 - 01/2019
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2021 - 01/2019
3	ponatinibIBA 01/2021 - 11/2015
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 01/2019
3	Biological ProductsIBA 01/2021 - 09/2013
3	midostaurinIBA 11/2019 - 04/2015
3	Hemoglobins (Hemoglobin)IBA 09/2019 - 09/2014
3	Phosphotransferases (Kinase)IBA 06/2018 - 08/2015
3	Gemtuzumab (Mylotarg)FDA Link 02/2017 - 08/2010
3	Histone Deacetylase InhibitorsIBA 01/2012 - 08/2010
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 08/2015
2	CreatinineIBA 01/2022 - 01/2022
2	fms-Like Tyrosine Kinase 3IBA 01/2021 - 08/2012
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 02/2017
2	MethyltransferasesIBA 01/2021 - 01/2019
2	Monoclonal AntibodiesIBA 01/2021 - 03/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2020 - 08/2010
2	nelarabine (506U78)FDA Link 11/2020 - 01/2018
2	NucleophosminIBA 10/2019 - 01/2019
2	NivolumabIBA 09/2019 - 01/2019
2	Transaminases (Aminotransferases)IBA 01/2018 - 06/2014
2	Janus KinasesIBA 01/2017 - 03/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2016 - 05/2015
2	Dexamethasone (Maxidex)FDA LinkGeneric 02/2016 - 05/2015
2	Alanine Transaminase (SGPT)IBA 01/2016 - 11/2015
2	Prednisone (Sone)FDA LinkGeneric 11/2015 - 09/2014
2	Aurora KinasesIBA 08/2015 - 06/2014
2	pomalidomideIBA 09/2014 - 11/2013
2	NucleosidesIBA 06/2014 - 11/2013
2	Vorinostat FDA Link 10/2010 - 08/2010
2	mocetinostatIBA 10/2010 - 08/2010
2	obatoclaxIBA 10/2010 - 08/2010
1	TriazolesIBA 10/2022

Therapy/Procedure

50	Therapeutics 10/2022 - 01/2010
30	Drug Therapy (Chemotherapy) 10/2022 - 11/2010
9	Induction Chemotherapy 01/2022 - 08/2010
7	Stem Cell Transplantation 01/2022 - 06/2011
3	Radiotherapy 10/2022 - 02/2012
3	Salvage Therapy 01/2021 - 01/2020
2	Drug Tapering 11/2021 - 11/2020
2	Consolidation Chemotherapy 01/2020 - 01/2018
1	Remission Induction 10/2022